We are building the future of Assisted Reproductive Technology?
At Spermotile, we’re pioneering a breakthrough in Assisted Reproductive Therapy (ART). Our focus is on identifying the highest quality ‘star sperms’ from semen samples for use in ART. With a flourishing family of intellectual properties, we’re now developing the Spermotile filtration system that ensures the best outcomes for fertility treatments.
We are currently funded by EU’s Horizon Europe Program and Research Council of Norway. We are a team of highly multidisciplinary scientists and engineers backed by a solid business development team.